A flexible or semi-flexible tube designed for the percutaneous, transluminal disruption and removal of clotted blood (i.e., a thrombus or thromboembolus) or other formed elements causing vascular obstruction in native/stented blood vessels, native/synthetic by
| Company | Devices | Share |
|---|---|---|
| Penumbra, Inc. | 290 | 50% |
| Stryker Corporation | 27 | 5% |
| Imperative Care, Inc. | 27 | 5% |
| Micro Therapeutics, Inc. | 22 | 4% |
| Teleflex Incorporated | 18 | 3% |
| Inari Medical, Inc. | 16 | 3% |
| Alembic, Llc | 15 | 3% |
| Balt Usa Llc | 14 | 2% |
| Vesalio | 13 | 2% |
| Boston Scientific Corporation | 12 | 2% |
| Shanghai Wallaby Medical Technologies Co., Inc. | 11 | 2% |
| Bayer Healthcare Llc | 10 | 2% |
Company = labeler of record on GUDID. 40 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| NRY | Catheter, Thrombus Retriever | 180 |
| QEW | Peripheral Mechanical Thrombectomy With Aspiration | 156 |
| NRY | CATHETER, THROMBUS RETRIEVER | 145 |
| DXE | Catheter, Embolectomy | 79 |
| KRA | Catheter, Continuous Flush | 51 |
| POL | Neurovascular Mechanical Thrombectomy Device for Acute Ische | 47 |
Use these as the dimensions to specify in a tender line.
581 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Thrombectomy suction catheter", from 40 companies. The largest labeler is Penumbra, Inc. with 50% of records.
NRY (Catheter, Thrombus Retriever), QEW (Peripheral Mechanical Thrombectomy With Aspiration), NRY (CATHETER, THROMBUS RETRIEVER), DXE (Catheter, Embolectomy)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add thrombectomy suction catheter to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.